FDC launches Favipiravir oral suspension to treat COVID-19 in India

By: |
July 12, 2021 4:16 PM

This prescription-only Favenza oral suspension is currently available at all retail medical outlets and hospital pharmacies across India, FDC said in a statement.

Pharma firm FDC Ltd , moderate cases of COVID-19 , oral suspension of Flavipiravir, Convenient loading dosage of the oral suspension ,battle against covidThis prescription-only Favenza oral suspension is currently available at all retail medical outlets

Pharma firm FDC Ltd on Monday said it has launched oral suspension of Favipiravir to treat mild to moderate cases of COVID-19 in the country.

This prescription-only Favenza oral suspension is currently available at all retail medical outlets and hospital pharmacies across India, FDC said in a statement. Convenient loading dosage of the oral suspension helps reduce dosage frequency, it added.

“With positive cases on the rise again, now is the time to provide healthcare warriors in our country with viable options in this continuous battle against this disease.

In order to combat COVID-19, we believe in offering best efficacy along with convenience to our patients and as such we have focused our efforts in making the process of COVID-19 treatment hassle-free,” FDC Business Development & Commercial Excellence General Manager Mayank Tikkha said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1COVID-19: Maha logs 6,126 new cases, 195 deaths; 7,436 recover
2Delhi records zero COVID-19 fatality, fifth time since onset of 2nd wave of pandemic; 67 cases
3Delhi govt caps Covid RT-PCR test rate in pvt labs, hospitals at Rs 500; antigen test to cost Rs 300